Markets:

Overview

News

Currencies

International

Treasuries

Longeveron Inc. - Class A Common stock (NQ:LGVN)

0.9735 +0.1645 (+20.33%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Longeveron Inc. - Class A Common stock

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

54 Biggest Movers From Yesterday ↗

November 19, 2021

Gainers Longeveron Inc. (NASDAQ: LGVN) shares climbed 135.3% to close at $6.87 on Thursday. Longeveron said the FDA granted rare pediatric disease designation for the company...

Via Benzinga

Mid-Afternoon Market Update: Dow Falls 75 Points; Dicerna Pharmaceuticals Shares Spike Higher ↗

November 18, 2021

Toward the end of trading Thursday, the Dow traded down 0.21% to 35,855.96 while the NASDAQ rose 0.16% to 15,946.49. The S&P also rose, gaining 0.19% to 4,697.80. The U.S. has...

Via Benzinga

Topics Stocks

LGVN Stock Alert: The Huge FDA News Sending Longeveron to the Moon Today ↗

November 18, 2021

Today, the FDA has smiled on Longeveron, with investors in LGVN stock seeing absolutely astronomical gains of more than 180% this morning.

Via InvestorPlace

Mid-Day Market Update: Macy's Surges After Q3 Results; Amtech Systems Shares Plunge ↗

November 18, 2021

Midway through trading Thursday, the Dow traded down 0.52% to 35,745.78 while the NASDAQ fell 0.22% to 15,886.57. The S&P also fell, dropping 0.16% to 4,681.24. The U.S. has...

Via Benzinga

Topics Stocks

44 Stocks Moving In Thursday's Mid-Day Session ↗

November 18, 2021

Gainers Longeveron Inc. (NASDAQ: LGVN) jumped 157% to $7.51. Longeveron said the FDA granted rare pediatric disease designation for the company’s Lomecel-B for the...

Via Benzinga

Why Are Longeveron Shares Skyrocketing On Thursday? ↗

November 18, 2021

The FDA has granted Rare Pediatric Disease (RPD) designation for Longeveron Inc's (NASDAQ: LGVN) Lomecel-B for Hypoplastic Left Heart Syndrome (HLHS)....

Via Benzinga

Mid-Morning Market Update: Markets Down; Kohl's Earnings Top Expectations ↗

November 18, 2021

Following the market opening Thursday, the Dow traded down 0.70% to 35,678.02 while the NASDAQ fell 0.36% to 15,863.49. The S&P also fell, dropping 0.24% to 4,677.46. The U.S...

Via Benzinga

Topics Stocks

FINAL DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

November 12, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Initial Public Offering Lawsuit

DEADLINE FRIDAY REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

November 10, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Initial Public Offering Lawsuit

Earnings Scheduled For November 12, 2021 ↗

November 12, 2021

Companies Reporting Before The Bell • Zevia (NYSE:ZVIA) is estimated to report quarterly loss at $0.43 per share on revenue of $34.40 million. • Natura &Co...

Via Benzinga

FRIDAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

November 09, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Initial Public Offering Lawsuit

FRIDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

November 08, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Initial Public Offering Lawsuit

ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Longeveron Inc. Investors to Secure Counsel Before Important November 12 Deadline in Securities Class Action – LGVN

November 07, 2021

From Rosen Law Firm

Via Business Wire

7-DAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

November 06, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Initial Public Offering Lawsuit

Last Few Days to Actively Participate in Longeveron Inc. (LGVN) Class Action - Bronstein, Gewirtz & Grossman, LLC

November 05, 2021

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

APPROACHING DEADLINE REMINDER: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against Longeveron Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

November 03, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Initial Public Offering Lawsuit

SHAREHOLDER ALERT: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Longeveron Inc. (LGVN)

November 03, 2021

From Longeveron

Via Business Wire

5 Cheap Stocks Set to Double This Month ↗

November 02, 2021

This article is excerpted from Tom Yeung's Moonshot Investor newsletter. To make sure you don't miss any of Tom's potential 100x picks, subscribe to his

Via InvestorPlace

NASDAQ:LGVN Investor Notice: Deadline on November 12, 2021 in Lawsuit Against Longeveron Inc. ↗

October 27, 2021

San Diego, CA -- (SBWIRE) -- 10/27/2021 -- The Shareholders Foundation announced that a deadline is coming up on November 12, 2021 in the lawsuit filed for certain investors of Longeveron Inc....

Via SBWire

Topics Initial Public Offering Lawsuit

3 Penny Stocks Insiders Are Buying ↗

October 15, 2021

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider...

Via Benzinga

2 Penny Stocks Insiders Are Buying ↗

October 13, 2021

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go...

Via Benzinga

ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Longeveron Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important November 12 Deadline in Securities Class Action – LGVN

October 09, 2021

From The Rosen Law Firm, P.A.

Via Business Wire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 04, 2021

Gainers Longeveron (NASDAQ:LGVN) shares ...

Via Benzinga

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs ↗

October 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...

Via Benzinga

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results ↗

October 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...

Via Benzinga

INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

October 04, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Initial Public Offering Lawsuit

Longeveron Successfully Advancing its Cell-Based Therapy Studies in a Growing Industry Segment ↗

October 04, 2021

Research and development of stem cell-based therapies, where a patient’s own cells, or those from a donor, are used to fight injury and disease, is one of the fastest...

Via Benzinga

Longeveron Announces Potential Biomarker Correlating with Lomecel-B Bioactivity ↗

September 29, 2021

Lomecel-B significantly decreased biomarker Tie-2 in Aging Frailty subjects at 270 days compared to placebo Significant, dose-dependent decrease in Tie-2 at Day 270 Oral...

Via Benzinga

NASDAQ:LGVN Investor Notice: Lawsuit Alleges Securities Laws Violations by Longeveron Inc. ↗

September 29, 2021

San Diego, CA -- (SBWIRE) -- 09/29/2021 -- An investor, who purchased shares of Longeveron Inc. (NASDAQ:LGVN), filed a lawsuit over alleged violations of Federal Securities Laws by Longeveron Inc. in...

Via SBWire

Topics Initial Public Offering Lawsuit Regulatory Compliance

EXCLUSIVE: Longeveron Announces Biomarker Analysis Data From Mid-Stage Study Of Anti-Aging Cell Therapy Candidate ↗

September 29, 2021

Longeveron Inc. (NASDAQ: LGVN) announced Wednesday positive biomarker analysis data from the mid-stage study of its lead cell therapy candidate in aging frailty subjects. What...

Via Benzinga

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.